Table 2.
Summary of characteristics of patients with acute limb ischemia.
| Variable | Value |
|---|---|
| Demographics | |
| Female sex, n (%) | 2 (20%) |
| Age (years), median (IQR) | 53.5 (53–63) |
| Risk factors, n (%) | |
| Diabetes Mellitus (type 2) | 7 (70%) |
| Hypertension | 4 (40%) |
| Smoking | 2 (20%) |
| Obesity | 2 (20%) |
| Dyslipidemia | 4 (40%) |
| Clinical severity of COVID-19 | |
| Asymptomatic | 0 (0%) |
| Mild | 0 (0%) |
| Moderate | 0 (0%) |
| Severe | 10 (100%) |
| Critical | 0 (0%) |
| Time from COVID-19 symptom onset to ALI symptom onset (days), median (IQR) | 14.5 days (11–15) |
| Grade of ALI (Rutherford Classification), n (%) | |
| I | 0 (0%) |
| IIa | 3 (30%) |
| IIb | 4 (40%) |
| III | 4 (40%) |
| Management of ALI, n (%) | |
| Systemic anticoagulation with UFH alone | 0 (0%) |
| Thrombectomy (open) and systemic anticoagulation with UFH (therapeutic dose) | 5 (50%) |
| Amputation (disarticulation) | 5 (50%) |
| Outcome, n (%) | |
| Revascularization | 5 (50%) |
| Amputation | 5 (50%) |
| In-hospital mortality | 0 (0%) |